Archive for February, 2021

$POAI Looks to AI to Improve Clinical Decision Making for Ovarian Cancer Patients

Predictive Oncology (NASDAQ: POAI), through its wholly owned subsidiary, Helomics, has sought to end the alarming statistics surrounding ovarian cancer. According to figures provided by the American Cancer Society and quoted by an article discussing POAI’s motivations and operations, “an estimated 21,750 women received a new diagnosis of ovarian cancer this year (2020), and almost 14,000 women will die from the disease. Those numbers make ovarian cancer the fifth-leading cause of cancer deaths in women.” In a bid to change this reality, Predictive Oncology, a company that focuses on using data and artificial intelligence to develop personalized cancer therapies, has partnered with the University of Pittsburg School of Medicine, through Helomics, “to study the use of artificial intelligence (‘AI’) to improve clinical decision making for ovarian cancer patients. The collaboration entails using Helomics’ AI platform and proprietary data to analyze the genomic and drug response profiles of women with ovarian cancer to evaluate predictive values in terms of response and non-response to different treatments… Helomics’ predictive models will save time and money in the search for new targeted therapies.”

To view the full article, visit: https://ibn.fm/qsDz5

About Predictive Oncology Inc.

Predictive Oncology operates through three segments (Skyline, Helomics and Soluble Biotech), which contain four subsidiaries: Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins, including vaccines, antibodies, large and small proteins and protein complexes. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $POAI Looks to AI to Improve Clinical Decision Making for Ovarian Cancer Patients

$PLTXF Releases Record-Breaking Gross Revenue for January 2021

  • Company reports record gross revenues of C$1,089,502 last month
  • “It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” states CEO
  • Record revenue comes during one of slowest e-commerce periods of year, highlighting impact the company has in the plant-based marketplace

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) saw record gross revenues last month (https://ibn.fm/qro4v). The company released its monthly numbers, noting that gross revenues for January 2021 totaled a record-breaking C$1,089,502; cost of goods sold for the month reached C$751,356.

“It is truly encouraging to achieve yet another incredible revenue milestone and to start the new year with such vigor and success,” said PlantX CEO Julia Frank. “There are many other colorful growth opportunities on the horizon, and we’re confident that our financial trajectory will reflect the remarkable and increasing value our company brings to the plant-based industry.”

PlantX Life stated that its January numbers surpassed its December 2020 gross revenues of $1,029,883, which were achieved during a highly dynamic holiday season. “This was surpassed by January 2021’s revenue, which exceeded management’s expectations given that e-commerce sales were expected to be slower following the holiday season,” the announcement noted. “This success during one of the slowest e-commerce periods of the year highlights the tremendous impact the company continues to have in the plant-based marketplace.” The announcement stated that the company’s growth reflects its commitment to meet consumer demand and continues to be driven by its innovative partnerships as well as its marketing and branding efforts.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, PlantX currently has plans to expand its product lines to include cosmetics, clothing and its own water brand.

In addition, the company uses its digital platform to build a community of like-minded consumers and to provide education. Its successful enterprise is being built and fortified through partnerships with top nutritionists, chefs and brands. For example, the company offers 20 unique pre-made meals designed by top chefs and nutritionists. These healthy meals are offered at extremely competitive prices with fast shipping and round-the-clock convenience.

The company’s commitment to customer service is the driving force behind its e-commerce platform, with innovative thinking driving its operation; the PlantX team is constantly envisioning new ways to collaborate with local restaurateurs and entrepreneurs to bring PlantX to the world. PlantX is committed to eliminating the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.

To learn more about this company, visit www.PlantX.comwww.PlantX.ca and www.Investor.PlantX.com and view the PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $PLTXF Releases Record-Breaking Gross Revenue for January 2021

$NETE Featured as $F Injects $1 Billion in Germany, Targets EU Market for EVs

Several countries across the world have set green-energy targets as the race toward electrifying the roads heats up. European countries have set what are probably the most ambitious targets, consequently pushing automakers towards adopting green energy much faster. American car maker Ford Motor Co. (NYSE: F), for instance, has unveiled plans to spend $1 billion on modernizing a factory in Cologne, Germany, as it works towards its target of selling only electric passenger cars on the continent by 2030.

According to the automaker, the plant will be overhauled and used to produce Ford’s first European-built, mass-volume electric passenger car starting in 2023. All the passenger cars Ford sells in Europe by mid-2026 will be either all-electric or plug-in hybrids with both an internal combustion engine as well as a rechargeable battery and an electric motor, the company says. Ultimately, Ford aims to sell only all-electric passenger cars to the European market by 2030.

Stuart Rowley, president of Ford Europe, says that after successfully restructuring the company’s European operations and turning a profit in the Q4 2020, Ford is now looking at an all-electric future in Europe. While tougher regulations by European countries have forced the company to start thinking about zero-emission cars, the move is also due to increased customer interest in electric vehicles, Rowley says. Electric vehicles have seen what he calls “very strong demand,” with more customers warming up to the idea of owning and driving a zero-emission vehicle.

The move comes a few weeks after Ford announced that it was going to invest at least $22 billion worldwide until 2025 to develop and produce battery electric vehicles. That figure is inclusive of the $7 billion the automaker already spent from 2016 to the end of 2020. This commitment toward shifting to green energy can partly be attributed to Europe’s stance on carbon emissions. The continent is home to some of the most aggressive emission targets, with companies that don’t comply facing huge potential fines.

Although Ford recently delivering the Mustang Mach-E, it still has a lot of catching up to do. Volkswagen, which in 2019 announced an alliance with Ford, currently enjoys the highest EV sales in the European market while global EV leader Tesla is currently building its first European gigafactory in Berlin that will produce batteries, powertrains and vehicles, starting with the best-selling Tesla Model 3.

Aside from the Mach-E, Ford has more electric vehicles on the way, including the E-Transit commercial van, which  will roll-out to American dealerships late this year and in Europe in early 2022.

Ranked among the top 500 tech companies by Deloitte, Net Element (NASDAQ: NETE) is set to enter the electric vehicle industry through a reverse merger with a California-based EV manufacturer.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $NETE Featured as $F Injects $1 Billion in Germany, Targets EU Market for EVs

$MWK Sees Outlook Rise as Result of Pandemic Trends

February 26, 2021
  • The COVID-19 pandemic is a year old, having devastated a number of markets since its discovery and spread were first reported in China
  • While many industries have suffered worldwide during the year, the distancing requirements instituted in response to the pandemic have led buyers to turn to online retail outlets for many products
  • Consumer products marketer Mohawk Group Holdings has been ideally situated to take advantage of the 44 percent growth in online commerce spending during 2020 and beyond
  • Mohawk’s stock took an initial beating with the outbreak of the pandemic, but has since rebounded and rose more than 400 percent during the past three months alone
  • The company’s holdings saw sales grow from $88.8 million to $144.2 million during the first nine months of 2020

Consumer products platform Mohawk Group Holdings (NASDAQ: MWK)  is riding a wave of optimism as an online retail marketer benefitting from the spike in remote access purchasing during the year-old COVID-19 pandemic.

Mohawk principally leverages its proprietary technology as a third-party seller on Amazon, and grew sales revenue from $88.8 million to $144.2 million during the first nine months of 2020 reported in its most recent quarterly filing (https://ibn.fm/TyCKQ).

An outside market opinion writer published this month in media outlet The Motley Fool noted that the company’s shares took a huge dive when the pandemic provoked strict commerce-limiting measures throughout the United States last year, but has also sharply rebounded.

“Yes, the stock is up over 400% in the past three months, but it is still early innings for this tech-enabled CPG (consumer packaged goods) conglomerate, so don’t fool yourself into thinking you’ve missed the boat with this business,” the opinion writer, Brett Schafer, states (https://ibn.fm/yV8Jc).

Schafer cited a Digital Commerce 360 report stating that e-commerce has experienced tremendous growth during the past year, with online shopping forming more than 20 percent of retail spending in the United States during 2020. The $861 billion spent online was a 44 percent increase over the previous year.

Amazon captured nearly a third of the online market share, with sales growth of 54 percent during the final quarter of the year. Mohawk’s position as a third-party Amazon seller allows it to ride the commerce giant’s coattails.

The company’s Artificial Intelligence Mohawk E-commerce Engine (“AIMEE”) helps it identify market opportunities then design, develop and launch products from its stable of 12 brands in categories including kitchenware and home appliances, environmental appliances, beauty products and consumer electronics.

Mohawk also sells its AIMEE software to other online sellers, granting the company revenue with high margins and a huge market opportunity. The company has offices in the United States, Canada, China and the Philippines and takes advantage of its global footprint to move its products around the clock.

The platform’s Fulfillment Engine helps to guide inventory location, cost optimization and use of third-party networks to cut shipping times.

When Mohawk announced the acquisition of online essential oils seller Healing Solutions, LLC in early February, the company reported it expects the acquisition to help boost its net revenues for 2021 to a range between $340 million to $370 million, with net income for the year estimated to reach between $1 million and $5 million primarily in response to quarterly interest expense, net and stock-based compensation expense.

Mohawk forecasts its adjusted EBITDA will be between $28 million and $32 million.

For more information, visit the company’s website at www.Mohawkgp.com.

NOTE TO INVESTORS: The latest news and updates relating to MWK are available in the company’s newsroom at https://ibn.fm/MWK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $MWK Sees Outlook Rise as Result of Pandemic Trends

$IDEX Joins National Nonprofit Working to Accelerate Clean Transportation

Ideanomics (NASDAQ: IDEX), a global company focused on the convergence of financial services and industries experiencing technological disruption, has announced that it has joined CALSTART as a full member. CALSTART is a nonprofit with more than 270 members around the country; the organization facilitates the development of the clean transportation technology industry. The membership allows IDEX access to CALSTART and stakeholder leadership as well as increased project partnership engagement and hands-on, participatory industry connections. Other members of the nonprofit include manufacturers, suppliers, fleets, technology firms, academic institutions, government agencies, NGOs, power companies, fuel providers, banks and more. In addition, CALSTART offers a specific proficiency at providing early adopters with leadership, connections and funding to speed up the deployment of game-changing technologies, which could prove to be beneficial as Ideanomics works on increasing global commercial EV adoption. Ideanomics anticipates that CALSTART membership will support its wholly owned subsidiaries, Wireless Advanced Vehicle Electrification (“WAVE”) and Medici Motor Works, in addition to its portfolio company Solectrac. “CALSTART provides Ideanomics with the network and expertise that will help us accelerate the adoption of WAVE’s technology,” said Ideanomics CEO Alf Poor in the press release. “The benefits of WAVE’s wireless charging systems are aligned with CALSTART’s mission, and with this membership, we can enhance our national and global programs.”

To view the full press release, visit https://ibn.fm/Cpljb

About Ideanomics

Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. The company’s Mobile Energy Global (“MEG”) division is a service provider that facilitates the adoption of electric vehicles by commercial fleet operators through offering vehicle procurement, finance and leasing, and energy-management solutions under its innovative sales to financing to charging (“S2F2C”) business model. Ideanomics Capital is focused on disruptive fintech solutions for the financial services industry. Together, MEG and Ideanomics Capital provide the company’s global customers and partners with leading technologies and services designed to improve transparency, efficiency and accountability, and provides IDEX shareholders with the opportunity to participate in high-potential, growth industries. For more information about the company, please visit www.Ideanomics.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $IDEX Joins National Nonprofit Working to Accelerate Clean Transportation

$CBDHF Common Shares Approved for DTC Full Service

HempFusion Wellness (TSX: CBD.U) (OTCQX: CBDHF) (FWB: 8OO), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, has announced that the Depository Trust Company (“DTC”) has approved its common shares for DTC full-service eligibility. The approval is for the United States and means that the common shares can now be both traded and serviced through DTC’s electronic book-entry system. A subsidiary of the Depository Trust & Clearing Corp. (“DTCC”), DTC provides clearing and settlement services for the financial markets; the entity also settles securities transactions in the United States. By utilizing this electronic method of clearing securities, the receipt of stock and cash goes faster, ultimately quickening the entire settlement process for investors and brokers and allowing stock to be traded over a wider selection of brokerage firms. “By offering electronic settlement, DTC eligibility provides us with a larger platform to attract investors,” said HempFusion co-founder and CEO Jason Mitchell in the press release. “From online trading platforms to banks to brokerage firms, the full spectrum of investors can now access our company resulting in more liquidity.”

To view the full press release, visit http://ibn.fm/Uank9

About HempFusion Wellness Inc.

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research and HF Labs, to approximately 4,000 retailers across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 46 SKUs (“SKUs”) including tinctures, proprietary FDA Drug Listed over-the-counter (“OTC”) topicals, doctor/practitioner lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex(TM) and are available in store or online. For more information about the company, visit www.HempFusion.com.

NOTE TO INVESTORS: The latest news and updates relating to CBDHF are available in the company’s newsroom at http://ibn.fm/CBDHF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $CBDHF Common Shares Approved for DTC Full Service

$BRSF Research on Sensitive Blood Test for Cancer Wins 2021 Top-10 Award

The Clinical Research Forum recently awarded cancer biologists from Weill Cornell Medicine its Top-10 Clinical Research Achievement Award for their 2020 study that described a sensitive blood test for detecting a cancer relapse or the disease’s progression. The findings of the study were reported in “Nature Medicine.”

The group of researchers was led by associate professor of medicine, Dr. Dan Landau, who is  also a member of the Sandra and Edward Meyer Cancer Center. The study’s first author…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to Brain Scientific Inc. (OTCQB: BRSF) are available in the company’s newsroom at http://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Friday, February 26th, 2021 Uncategorized Comments Off on $BRSF Research on Sensitive Blood Test for Cancer Wins 2021 Top-10 Award

$FRSX Announces Fourth Quarter and Full Year 2020 Financial Results

Foresight Autonomous Holdings Ltd., an innovator in automotive vision systems (Nasdaq and TASE: FRSX), today reported financial results for the fourth quarter and full year 2020. Foresight ended the fourth quarter of 2020 with $43.9 million in cash and short-term deposits.

Foresight reported a GAAP operating loss of $12.84 million for the full year 2020 which is an approximately 15% less than the GAAP operating loss of $15.03 million reported for the full year 2019. Foresight reported a GAAP net loss of $3.96 million and $15.32 million for the fourth quarter 2020 and the full year, respectively, and a non-GAAP net loss of $3.71 million for the fourth quarter and $14.16 million for the full year 2020.

“We achieved important key milestones during the fourth quarter of 2020 and maintained solid progress throughout the year in spite of the COVID-19 pandemic,” said Haim Siboni, Foresight’s CEO. “We are entering 2021 with a strong balance sheet, following successful capital raises including $26 million raised in our registered direct offering announced on December 28, 2020. We will continue to build on our innovative product portfolio, which has been validated through key prototype orders and partnerships in Europe, Asia and North America.”

“The successful year also extends to our subsidiary, Eye-Net Mobile, and our affiliate, Rail Vision. Both companies achieved major business milestones during the fourth quarter of 2020, as Rail Vision received a second investment of $10 million from a leading Tier One European-based group, Knorr-Bremse, in October 2020, and Eye-Net Mobile signed a distribution agreement with Cornes Technologies, a leading Japanese trading house. We believe that Rail Vision and Eye-Net Mobile are poised for further growth in 2021,” concluded Mr. Siboni.

Fourth Quarter 2020 Financial Results

  • Research and development (R&D) expenses, net for the fourth quarter of 2020 were $2,189,000 compared to $3,203,000 in the fourth quarter of 2019. The decrease is attributed mainly to a decrease in subcontracted and consulting services, decreases in payroll and related expenses (attributed to the reorganization of the field application engineering, sales & marketing, and R&D departments made in the fourth quarter of 2019) and decreases in travel expenses.
  • General and administrative (G&A) expenses for the fourth quarter 2020 were $793,000 compared to $803,000 in the fourth quarter of 2019.
  • GAAP net loss for the fourth quarter of 2020 was $3,964,000 compared to a GAAP net loss of $4,370,000 in the fourth quarter of 2019. The decrease is attributed mainly to the decrease in R&D expenses, offset by the increase in marketing and sales expenses.
  • Non-GAAP net loss for the fourth quarter of 2020 was $3,712,000 compared to a non-GAAP net loss of $4,018,000 in the fourth quarter of 2019. A reconciliation between GAAP net loss and non-GAAP net loss is provided following the financial statements that are part of this release. Non-GAAP results exclude the effect of share-based compensation expenses.

Full Year 2020 Financial Results

  • R&D expenses, net for the full year ended December 31, 2020 were $8,563,000, compared to $10,210,000, in the full year ended December 31, 2019. The decrease is attributed mainly to a decrease in subcontracted and consulting services and travel expenses, offset by an increase in payroll and related expenses. The decrease in R&D expenses is a result of the reduction in the monthly operating expenses made by the Company during the second quarter of 2020 due to the COVID-19 outbreak.
  • G&A expenses for the full year ended December 31, 2020 were $3,005,000, compared to $3,469,000 in the full year ended December 31, 2019. The decrease is attributed mainly to a decrease in payroll and related expenses and a decrease in professional services.
  • GAAP net loss for the full year ended December 31, 2020 was $15,324,000 compared to a GAAP net loss of $15,439,000 in the full year ended December 31, 2019.
  • Non-GAAP net loss for the full year ended December 31, 2020 was $14,162,000 compared to a non-GAAP net loss of $13,476,000 in the full year ended December 31, 2019. The increase is attributed to the increase in equity in the net loss of an affiliated company. A reconciliation between GAAP net loss and non-GAAP net loss is provided following the financial statements that are part of this release. Non-GAAP results exclude the effect of share-based compensation expenses, revaluation of other investments and revaluation of derivative warrant liability expenses.

Full year ended
December 31,

Three months ended
December 31,

(thousands of U.S. dollars)

2020

2019

2020

2019

GAAP Results

Net loss

$(15,324)

$(15,439)

$(3,964)

$(4,370)

Non-GAAP Results

Net loss

$(14,162)

$(13,476)

$(3,712)

$(4,018)

Balance Sheet Highlights

  • Cash and short-term deposits totaled $43.9 million as of December 31, 2020, compared to $10.1 million as of December 31, 2019.
  • Investments in Rail Vision Ltd. totaled $4.1 million as of December 31, 2020, compared to $6.7 million as of December 31, 2019. The decrease is attributed primarily to Foresight’s exposure to Rail Vision’s net loss in 2020. As of December 31, 2020, we no longer have a significant influence in Rail Vision Ltd., due to a decrease in our holdings and voting rights resulting from the dilution that occurred in October 2020 as a result of Knorr Bremse’s additional investment in Rail Vision Ltd. As a result, we stopped using the equity method for accounting purposes as of suchdate and started measuring the investment in Rail Vision based on its actual cost offset by impairment.
  • GAAP total equity totaled $47.1 million as of December 31, 2020, compared to $16.3 million as of December 31, 2019. The increase is attributed to the receipt of proceeds from the securities offerings completed in 2020 offset by the net loss accrued during the same period.
  • Non-GAAP total equity totaled $47.1 million as of December 31, 2020, compared to $16.6 million as of December 31, 2019.
  • A reconciliation between GAAP total equity results and non-GAAP total equity results is provided following the financial statements that are part of this release. Non-GAAP results exclude revaluation of other investments.

Fourth Quarter Corporate Highlights :

  • Foresight Prices $26 Million Registered Direct Offering: On December 28, 2020, Foresight announced that it entered into agreements with investors for the purchase and sale of 6,265,063 of American Depositary Shares (ADS) at a price of $4.15 per ADS. The gross proceeds of the offering were approximately $26 million, which will be used for working capital and other general corporate purposes.
  • Foresight Executed Sales Agreement : On October 2, 2020, Foresight entered into a sales agreement with A.G.P./Alliance Global Partners, pursuant to which it was able to offer and sell up to $8.1 million of its ADSs from time to time. The offering has been fully exhausted.
  • Foresight Completes Integration of NVIDIA Platforms for Use in Autonomous Machines and Vehicles: In November 2020, Foresight completed integration of its QuadSight ® software on the NVIDIA ® Jetson AGX Xavier™ platform, enabling shuttles, agriculture equipment and heavy equipment machines to operate Foresight’s stereoscopic obstacle detection software. Foresight also joined the NVIDIA Inception program, providing go-to-market support, technological assistance and expertise to AI startups using NVIDIA processing units.
  • Rail Vision Receives Order for Electrically Powered Light Rail Vehicle Systems from Knorr-Bremse: Rail Vision entered the multi-billion-dollar electrically powered light rail market with an order for two system samples from Knorr-Bremse in December 2020. Additionally, Knorr-Bremse ordered the customization of system features according to its requirements. Revenue from the sale is expected to total approximately 400,000 Euro.
  • Foresight to Take Part in Automation of Future Heavy-Duty Vehicles European Project: As part of the Horizon 2020 framework program, the European Commission awarded a grant of nearly 20 million Euro for the All-Weather Autonomous Real logistics operations and Demonstrations (AWARD) consortium. The project intends to develop and safely operate autonomous heavy-duty vehicles in harsh weather conditions. Foresight will provide its QuadSight ® multispectral vision solution to the project and is expected to receive approximately $1 million, out of which approximately $0.5 million has been received.
  • Eye-Net Mobile Signs Distribution Agreement with Leading Japanese Trading House: In October 2020, Eye-Net Mobile announced a distribution agreement with Cornes Technologies, a leading Japanese trading house. According to the agreement, Cornes Technologies will promote the Eye-Net™ cellular-based accident prevention suite in products and applications of third parties in Japan. The distribution agreement follows multiple successful pilot projects with Japanese multinational companies, as well as ongoing interest from additional Japanese companies.
  • Rail Vision Receives $10 Million Investment from Leading Tier One European Based Knorr-Bremse: Following an initial investment of $10 million in March 2019, Knorr-Bremse made an additional investment of $10 million in Rail Vision in October 2020. Following the additional investment, Knorr-Bremse owns 36.79% of Rail Vision’s outstanding capital. The investment reflected Rail Vision’s post-money valuation of approximately $50 million. As a result of the investment, Foresight’s holdings in Rail Vision amount to 19.34% (16.49% on a fully diluted basis).
  • Foresight Launches COVID-19 Mass Screening Solution in Japan; Showcases Solution in United Arab Emirates: Foresight launched its COVID-19 symptom detection mass screening solution at SEECAT 2020, a technology exhibition targeting the public defense and safety sectors. A leading Japanese trading house presented Foresight’s solution at the exhibition, which took place in October 2020 in Tokyo, Japan. In December 2020, Foresight exhibited the same solution at the GITEX Future Stars 2020 conference in the United Arab Emirates. The mass screening solution leverages Foresight’s expertise in thermal and visible light cameras to detect several symptoms of COVID-19.
  • Foresight Partners with University of Michigan TechLab at MCity: In December 2020, Foresight announced that it will join the 2021 startup cohort at the University of Michigan’s TechLab at MCity. During the one-year program, Foresight will work with students from the University of Michigan to further develop its automotive vision system designed for Advanced Driver Assistance Systems and autonomous vehicles. The team will be mentored by Foresight’s Head of Algorithm and other leading Foresight employees.

Use of Non-GAAP Financial Results

In addition to disclosing financial results calculated in accordance with United States generally accepted accounting principles (GAAP), the company’s earnings release contains non-GAAP financial measures of net loss for the period that excludes the effect of share-based compensation expenses, the revaluation of other investments and revaluation of derivative warrant liability, and non-GAAP financial measures of shareholders’ equity that excludes the effect of derivative warrant liability and the revaluation of other investments. The company’s management believes the non-GAAP financial information provided in this release is useful to investors’ understanding and assessment of the company’s ongoing operations. Management also uses both GAAP and non-GAAP information in evaluating and operating business internally and as such deemed it important to provide all this information to investors. The non-GAAP financial measures disclosed by the company should not be considered in isolation or as a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations to those financial statements should be carefully evaluated. Reconciliations between GAAP measures and non-GAAP measures are provided later in this press release.

About Foresight

Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions.

Foresight’s vision solutions include modules of automatic calibration, sensor fusion and dense 3D point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.foresightauto.com , follow @ForesightAuto1 on Twitter, or join Foresight Automotive on LinkedIn.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and similar expressions or variations of such words are intended to identify forward-looking statements. For example, Foresight is using forward-looking statements in this press release when it discusses its belief that it is entering 2021 with a strong balance sheet, that it will continue to build on its innovative product portfolio, which it believes has been validated through key prototype orders and partnerships in Europe, Asia and North America, that it believes that Rail Vision and Eye-Net Mobile are poised for further growth in 2021, Rail Vision’s expected revenue from Knorr-Bremse, and that Foresight will work with students from the University of Michigan to further develop its automotive vision system designed for Advanced Driver Assistance Systems and autonomous vehicles. Because such statements deal with future events and are based on Foresight’s current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Foresight could differ materially from those described in or implied by the statements in this press release. The forward-looking statements contained or implied in this press release are subject to other risks and uncertainties, including those discussed under the heading “Risk Factors” in Foresight’s annual report on Form 20-F filed with the Securities and Exchange Commission (“SEC”) on March 31, 2020, and in any subsequent filings with the SEC. Except as otherwise required by law, Foresight undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. References and links to websites have been provided as a convenience, and the information contained on such websites is not incorporated by reference into this press release.

FORESIGHT AUTONOMOUS HOLDINGS LTD.

INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS

U.S. dollars in thousands

As of
December
31, 2020
(Unaudited)

As of
December
31, 2019

ASSETS

Current assets:

Cash and cash equivalents

$

38,772

$

4,827

Short term deposits

5,166

5,233

Marketable equity securities

42

23

Other receivables

401

613

Total current assets

44,381

10,696

Non-current assets:

ROU asset

1,104

1,278

Investment in equity securities

4,062

Investment in affiliate company

6,729

Fixed assets, net

427

631

5,593

8,638

Total assets

$

49,974

$

19,334

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current liabilities:

Trade payables

$

391

$

498

Operating lease liability

427

411

Other accounts payables

1,207

1,130

Total current liabilities

2,025

2,039

Non-current liabilities:

Operating lease liability

853

1,007

Total liabilities

2,878

3,046

Shareholders’ equity:

Ordinary shares of NIS 0 par value;

Additional paid-in capital

111,739

65,681

Accumulated deficit

(64,717

)

(49,393

)

Total Foresight Autonomous Holdings LTD. shareholders’ equity

47,022

16,288

Non-Controlling Interest

74

Total equity

47,096

16,288

Total liabilities and shareholders’ equity

$

49,974

$

19,334

FORESIGHT AUTONOMOUS HOLDINGS LTD.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

U.S. dollars in thousands

Year ended
December 31,

Three months ended
December 31,

2020

(Unaudited)

2019

2020

(Unaudited)

2019

Research and development expenses, net

(8,563)

(10,210)

(2,189)

(3,203)

Marketing and sales

(1,268)

(1,350)

(295)

266

General and administrative expenses

(3,005)

(3,469)

(793)

(803)

Operating loss

(12,836)

(15,029)

(3,277)

(3,740)

Equity in net loss of an affiliated company

(2,667)

(839)

(668)

(671)

Financing income (expenses), net

179

429

(19)

41

Net loss

(15,324)

(15,439)

(3,964)

(4,370)

FORESIGHT AUTONOMOUS HOLDINGS LTD.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

U.S. dollars in thousands

Year ended
December 31,

Three months ended
December 31,

2020
(Unaudited)

2019

2020
(Unaudited)

2019

Net cash used in operating activities

Loss for the Period

(15,324)

(15,439)

(3,964)

(4,370)

Adjustments to reconcile profit to net cash used in operating activities:

3,829

3,578

977

1,319

Net cash used in operating activities

(11,495)

(11,861)

(2,987)

(3,051)

Cash Flows from Investing Activities

Changes in short term deposits

67

7,273

(24)

2,835

Proceeds from other investments

21

Proceed from sales of marketable equity securities

68

Purchase of fixed assets

(50)

(103)

(2)

(30)

Net cash provided by (used in) investing activities

85

7,191

(26)

2,805

Cash flows from Financing Activities:

Issuance of ordinary shares, net of issuance expenses

45,017

6,521

32,088

Exercise of options, net of issuance expenses

263

263

Net cash provided by financing activities

45,280

6,521

32,351

Effect of exchange rate changes on cash and cash equivalents

75

(182)

39

3

Increase (decrease) in cash and cash equivalents

33,945

1,669

29,377

(243)

Cash and cash equivalents at the beginning of the period

4,827

3,158

9,395

5,070

Cash and cash equivalents at the end of the period

38,772

4,827

38,772

4,827

FORESIGHT AUTONOMOUS HOLDINGS LTD.

INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW

U.S. dollars in thousands

Adjustments to reconcile profit (loss) to net cash used in operating activities:

Year ended
December 31,

Three months ended
December 31,

2020
(Unaudited)

2019

2020
(Unaudited)

2019

Share-based payment

1,162

1,638

252

352

Depreciation

254

259

62

66

Revaluation of derivative warrant liability

1

Equity in loss of an affiliated company

2,667

839

668

671

Revaluation of marketable equity securities

(87)

(23)

13

Revaluation of other investments

324

exchange rate changes on cash and cash equivalents

(75)

182

(39)

(3)

Changes in assets and liabilities:

Decrease (increase) in other receivables

212

(142)

45

160

Increase (decrease) in trade payables

(296)

154

14

(177)

Change in operating lease liability

60

110

75

5

Increase (decrease) in other accounts payable

(68)

213

(77)

232

Adjustments to reconcile loss to net cash used in operating activities

3,829

3,578

977

1,319

Non-Cash activities

Year ended

Three months ended

December 31,

December 31,

2020
(Unaudited)

2019

2020
(Unaudited)

2019

Accrued issuance expenses recorded in equity

310

310

FORESIGHT AUTONOMOUS HOLDINGS LTD.

SUPPLEMENTAL RECONCILIATION OF GAAP TO NON-GAAP SHAREHOLDERS’ EQUITY

(Unaudited) U.S. dollars in thousands

As of
December 31,
2020

As of
December 31,
2019

GAAP Total equity

47,096

16,288

Revaluation of other investments

324

Non-GAAP Total equity

47,096

16,612

SUPPLEMENTAL RECONCILIATION OF GAAP TO NON-GAAP RESULTS

(Unaudited) U.S. dollars in thousands

Year ended
December 31

Three months ended
December 31,

2020

2019

2020

2019

GAAP operating loss

(12,836)

(15,029)

(3,277)

(3,740)

Share-based compensation in research and development

469

568

95

126

Share-based compensation in sales and marketing

62

214

16

62

Share-based compensation in general and administrative

631

856

141

164

Non-GAAP operating loss

(11,674)

(13,391)

(3,025)

(3,388)

GAAP Financing income (expenses), net

179

429

(19)

41

Revaluation of other investments

324

Revaluation of derivative warrant liability expense

1

Non-GAAP Financing income (expenses), net

179

754

(19)

41

GAAP net loss

(15,324)

(15,439)

(3,964)

(4,370)

Share-based compensation expenses

1,162

1,638

252

352

Revaluation of other investments

324

Revaluation of derivative warrant liability expenses

1

Non-GAAP net loss

(14,162)

(13,476)

(3,712)

(4,018)

Investor Relations Contact:
Miri Segal-Scharia
CEO
MS-IR LLC
msegal@ms-ir.com
917-607-8654

Thursday, February 25th, 2021 Uncategorized Comments Off on $FRSX Announces Fourth Quarter and Full Year 2020 Financial Results

$XPHYF Massachusetts Legislators Introduce Bills to Study Psychedelics, Remove Criminal Penalties

Last week, legislators in Massachusetts introduced initiatives that may help end the war on drugs in the state. One measure would establish a task force whose focus will be to study fungi and plant-based psychedelics, its objective being to regulate and legalize these substances. The  second other proposal would do away with criminal penalties for drug possession.

This isn’t the only call to end criminal prohibition in the state. Recently, the city councils of Cambridge and Somerville adopted initiatives that made possession of psychedelics among the lowest law enforcement priorities for their municipalities.

HD 3439, which was introduced to the House by Reps. Mike Connolly and Liz Miranda, would establish a civil fine of $50 for possession of controlled substances. SD 2248, a senate version of the bill that is almost identical to the House legislation, was introduced by Senator Julian Andre Cyr. A separate House legislation that would take the state past decriminalization and permit regulated sales of some drugs was also introduced by Connolly.

To begin with, HD 3829 would set up an interorganizational task force whose purpose would be to study the social justice and public health consequences of legalizing the distribution, consumption, transportation and possession of naturally grown, entheogenic fungi and plants. The legislation states that the task force, which will be made up of 21 people, will study the effects of fungi and plant-based psychedelics and provide suggestions regarding how to legalize these psychedelic substances in a way that would maximize both the sustainable manufacture of these entheogens as well as equitable access.

The initiative also demands that the task force provide counsel around “equity and expungement measures, diversion, parole and pardons” for individuals who have criminal records because of the distribution or possession of controlled substances.

Massachusetts is not the only state considering measures that do away with drug penalties. In California, Sen. Scott Wiener introduced a bill that would legalize the social sharing and possession of some drugs including MDMA, psilocybin mushrooms, DMT, LSD, ibogaine, mescaline and ketamine. The legislation would also offer expungement of past criminal records for the use or possession of psychedelic substances.

Additionally, the state of California would set up a task force under the initiative to study the possible future systems of regulation around psychedelics. The task force will be required to present a report on its findings by 2024.

Lawmakers in the states of VirginiaConnecticutWashington StateFloridaKansas and Hawaii are also considering drug policy and psychedelics reform legislations for the 2021 session.

The momentum in favor of psychedelics is also manifesting on the business front. For instance, XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) has set its sights on producing active pharmaceutical ingredients (“API”) from psychedelic compounds on an industrial scale.

NOTE TO INVESTORS: The latest news and updates relating to XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) are available in the company’s newsroom at https://ibn.fm/XPHYF

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $XPHYF Massachusetts Legislators Introduce Bills to Study Psychedelics, Remove Criminal Penalties

$WRAP Reports New BolaWrap Deployments

TEMPE, Ariz., Feb. 25, 2021  — Wrap Technologies, Inc. (the “Company” or “WRAP”) (Nasdaq: WRAP ), an innovator of modern policing solutions, today reported seven new BolaWrap deployments on suspects in the field by agencies in New York, California, Texas, and South Carolina. The Company was informed of the deployments over the last two weeks. These wraps are in addition to the deployment by the Buffalo Police Department reported by the media earlier this week.

Two wraps were deployed on suspects by an agency in Texas, two wraps were deployed by an agency in California, two wraps were deployed by two different agencies in New York, and one wrap was deployed by an agency in South Carolina.

“We are pleased to see the continued use of the BolaWrap in the field as more and more agencies across the United States adopt the device onto their duty belts,” said Tom Smith, President of WRAP. “As agencies consider use of the BolaWrap as a very low level of force option, many uses are not reported to us and many agencies don’t even consider BolaWrap deployments a reportable use of force. So while we don’t always hear about deployments right away, we are excited to share periodic field use updates with our stakeholders.”

Links to recent media featuring the BolaWrap during the month of February can be found below.

Baldwin County Sheriff’s Office, Alabama
Glenwood Springs Police Department, Colorado
West Plains Police Department, Missouri
St. Landry Parish Sheriff’s Office, Louisiana
Hyattsville Police Department, Maryland
Canajoharie Police Department, New York
Portland Police Department, Maine
Philadelphia Police Department, Pennsylvania
LaGrange Police Department, Georgia
Utah Law Enforcement Agencies

About WRAP
WRAP Technologies, Inc. is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar® tether to restrain an individual at a distance from 10 to 25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement in safely and effectively deescalating encounters, especially those involving an individual in crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in a number of cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, and Oak Ridge. For information on the Company, please visit www.wrap.com.

Follow WRAP here:

WRAP on Facebook: https://www.facebook.com/wraptechnologies/
WRAP on Twitter: https://twitter.com/wraptechinc
WRAP on LinkedIn: https://www.linkedin.com/company/wraptechnologies/

Trademark Information
BolaWrap and Wrap are trademarks of WRAP Technologies, Inc. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to: statements regarding the Company’s overall business; total addressable market; and, expectations regarding future sales and expenses. Words such as “expect”, “anticipate”, “should”, “believe”, “target”, “project”, “goals”, “estimate”, “potential”, “predict”, “may”, “will”, “could”, “intend”, and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successful implement training programs for the use of its products; the Company’s ability to manufacture and produce product for its customers; the Company’s ability to develop sales for its new product solution; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company’s product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for counties outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

WRAP Contact:

Paul M. Manley
VP – Investor Relations
(612) 834-1804
pmanley@wrap.com

Thursday, February 25th, 2021 Uncategorized Comments Off on $WRAP Reports New BolaWrap Deployments

$UEC CEO Talks Domestic Uranium Production, UEC Seizing Opportunity During Recent Podcast Appearance

  • UEC president CEO Amir Adnani is featured on a recent episode of Bell2Bell Podcast.
  • Adnani notes that Uranium Energy Corp. is focused on rebuilding, restarting a domestic infrastructure to mine uranium for carbon-free nuclear energy.
  • The Company’s production area in the Burke Hollow project is the newest, largest ISR well field being developed in the country.

Uranium Energy (NYSE American: UEC) president and CEO Amir Adnani was featured on a recent episode of The Bell2Bell Podcast (https://ibn.fm/6mYtD), a podcast series focused on providing informative updates and exclusive interviews with executives leading companies that are operating in fast-moving industries. Under Adnani’s guidance, Uranium Energy advanced from concept to U.S. production in its first five years of operation; UEC currently has an extensive pipeline of low-cost, near-term production projects.

“Uranium Energy Corp. is a U.S.-focused developer of uranium projects using the low-cost and environmentally friendly in-situ recovery (‘ISR’) method,” said Adnani during the podcast as he provided an overview of the company’s business model. “In South Texas, we have our hub and spoke strategy. This is anchored by our fully licensed Hobson Processing Facility, one of only a few uranium processing plants in the country. We have a number of projects . . . which will be a source of U.S.-mined uranium.”

In addition to discussing the company’s business model, Adnani touched on recent company news, specifically talking about the company’s plans moving forward as the United States looks to decrease its reliance on carbon-based fuels. “Uranium is used for generating electricity in nuclear power plants, and 55% of U.S. carbon-free energy comes from nuclear power,” he said, noting that almost all of the uranium currently needed in the country to fuel reactors is coming from foreign sources.

“We have completely lost the ability to mine uranium in the U.S. from domestic sources,” he continued. “You and I both know the importance of local sources of vital needs, be it energy sources, be it masks, be it pharmaceuticals. So what we’re trying to do is to really rebuild and restart the domestic foundation to mine uranium — the fuel that is needed to run our 94 reactors in this country.”

During the interview, Adnani talked about the federal government’s bipartisan support of a U.S. Uranium Reserve and the allocation of funds to purchase uranium produced by U.S. mines, noting that he’d never seen such a move in his extensive experience in the industry. “[UEC] is getting ready to supply uranium to the global market and this new U.S. reserve,” he noted, pointing to the company’s Burke Hollow project, located in Texas. Burke Hollow’s initial production area is the newest and largest ISR well field being developed in the country (https://ibn.fm/6Br4k).

“We need to have a foundation to mine uranium domestically in the United States,” Adnani stated. “We’re rising to that occasion as a company. As a company we are today, at our Burke Hollow project… currently building one of the largest production areas currently in the United States…We have rigs on the property, we’ve got local staff, our team. We’re hiring locally. We’re creating jobs and adding to the economic development of the local communities that we’re in, in Texas…These are incredible opportunities, because not only are we creating local jobs…we’re also tying it back to developing the ability to mine uranium domestically. And again, this dovetails strategically with our plans to be a key supplier to the U.S Uranium Reserve.”

Adnani also talked about the strength of the company’s portfolio, which includes projects in Texas, Wyoming, New Mexico, Colorado and Arizona, as well as Canada and Paraguay, noting that the company looks to be ideally positioned as the market looks to expand and grow.

Uranium Energy Corp. is a U.S.-based uranium mining and exploration company that controls one of the country’s largest historical uranium exploration and development databases. Founded in 2003, UEC is headquartered in Corpus Christi, Texas.

For more information, visit the company’s website at www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $UEC CEO Talks Domestic Uranium Production, UEC Seizing Opportunity During Recent Podcast Appearance

$WTER Partner with Yesway to Carry A88CBD(TM) Products in Midwest C Stores

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER) has finalized an agreement with Yesway/Allsup convenience stores to A88CBD(TM) ingestibles in an estimated 365 C stores in the Midwest. The Alkaline Water Company is a producer of premium bottled alkaline water, flavor-infused waters, and CBD infused products sold under the brand names Alkaline88(R), A88 Infused(TM), and A88CBD, respectively. Yesway is No. 17 on Convenience Store Products (“CSP”) 2020 top-200 stores, calculated by number of retail outlets. Yesway is working to grow its portfolio to more than 500 convenience stores. “We are excited to announce that our A88CBD lemon-lime flavored water and four flavors of our gummies will be carried by one of the fastest-growing convenience stores chains in the U.S.,” said The Alkaline Water Company president and CEO Ricky Wright in the press release. “Yesway merged with Allsup stores in November of 2019 to create a leading c-store operator with almost 402 retail locations and growing. This is a meaningful win for our A88CBD brand and came in coordination with our CBD-focused DSD partner, BettermentRS. They will also assist with fulfillment efforts to all Yesway stores. Our recent engagement with BettermentRS is off to a great start. This will be the first of many wins with BettermentRS, and we are excited to be working with a great partner.”

To view the full press release, visit http://cnw.fm/gQzCr

About The Alkaline Water Company

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88(R) delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88(R) launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused(TM) flavored water is available in seven unique all-natural flavors, with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, please visit www.A88CBD.com and www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $WTER Partner with Yesway to Carry A88CBD(TM) Products in Midwest C Stores

$TOBAF Smoking Alternative Featured in Exclusive Broadcast

TAAT(TM) (CSE: TAAT) (OTCQB: TOBAF) (FRANKFURT: 2TP2) today announced the availability of a broadcast titled, “Beyond Tobacco: TAAT Innovation Delivers New Smoking Alternative.” The piece covers health and wellness as a top priority in today’s world, which has created a global climate of consumers clamoring for choices that offer the same experiences they’ve come to enjoy but with different ingredients. TAAT meets this growing demand in bringing the “same format, different ingredients” model to the smoking market like no one before. With senior leadership combining extensive experience in “big tobacco,” the life sciences company has developed its products to closely replicate a conventional cigarette while changing the composition to offer a tobacco-free alternative.

To view the full press release, visit https://ibn.fm/ATEQF

About TAAT(TM) Lifestyle & Wellness Ltd.

The company has developed TAAT(TM), which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in “Original,” “Smooth” and “Menthol” varieties. TAAT(TM)’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with “big tobacco” pedigree, TAAT(TM) was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $TOBAF Smoking Alternative Featured in Exclusive Broadcast

$SYTA Announces Largest Police Force Purchase Order to Date for UV350

Siyata Mobile (NASDAQ: SYTA, SYTAW), a leading global developer and provider of cellular communications solutions for enterprise customers, today announced its receipt of a purchase order to equip 600 police vehicles with the UV350, the company’s flagship, purpose-built, in-vehicle, all-in-one communication device. The company expects to deliver this order in the first quarter and increase to 1,200 vehicles during the remainder of 2021. “This agreement marks the largest police force purchase order Siyata has received to date, which we believe underscores the UV350’s unique utility for first responders,” said Marc Seelenfreund, CEO of Siyata Mobile. “Among the important attributes of the UV350 is its nationwide coverage, coupled with the ability for various first responder groups to instantly communicate with one another on the same network. With the benefits of an all-in-one communication device, we believe that the UV350 will continue to strongly resonate within the first responder community and be an asset that increases efficiency and reliability.”

To view the full press release, visit http://ibn.fm/aS8Db

About Siyata

Siyata Mobile Inc. is a B2B global vendor of next-generation push-to-talk over cellular (“PoC”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to improve communication, increase situational awareness and save lives.

Its portfolio of enterprise cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible.

Visit www.SiyataMobile.com and www.UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at http://ibn.fm/SYTA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $SYTA Announces Largest Police Force Purchase Order to Date for UV350

$POAI Study Discovers That Protein Imbalance May Cause Cataracts

Cataracts are a common eye disease, and while researchers have yet to fully understand how the disease works, plenty of research has been done on this ailment. Recently, a group of researchers at the Technical University of Munich (“TUM”) found that the composition of the protein solution was a factor in the disease. The researchers’ findings go against the field’s popular opinion.

TUM’s chair of biotechnology Prof. Johannes Buchner explained that the cells in an eye lens are comprised of a protein solution that is highly concentrated and normally clear. However, he continued, a protein imbalance may cause the proteins to lump together, which makes the lens cloudy, thus resulting in the condition known as cataracts.

This is not the only cause of the lens becoming cloudy, as the protein found in the lens is usually developed in the embryo and isn’t replaced. This means that damage that has accumulated over the years may also be causing clouding of the lens. This explains why cataracts primarily occur in older individuals.

However, some people have a genetic predisposition to cataracts, which causes mutations in proteins in their eye lens. In such cases, cataracts usually are present at birth or appear during childhood.

During their study, the researchers examined strains of mice that were impacted by hereditary cataracts. They partnered up with a researcher from Jochen Graw’s lab, an eye lens expert and a former professor at the Helmholtz Zentrum München Institute of Development Genetics.

Until now, the prevailing opinion had stated that only the defective eye proteins reacted with one another, thus forming clumps. However, Buchner’s group of researchers has demonstrated that in the mice with hereditary cataracts, this did not happen. Buchner explained that instead they found that the unstable, mutated proteins in the lens had been eliminated immediately, and it was the healthy proteins in the lens that clumped together.

Their model, which was based off of these insights, states that the balance between different proteins or their ratios to each other is crucial because, when either of these components goes missing, the remaining components join to form clumps. Additionally, Buchner noted that while a lot of research had been conducted to understand what brought about cataracts, never had any study carried out such an extensive study of lenses in mice, which compared mutants and wild populations.

He asserted that these new discoveries were vital in the search for new cataract treatments, with the current and most common treatment method being surgery.

Speaking of diseases linked to imbalances within the body, Predictive Oncology (NASDAQ: POAI) has a fully owned subsidiary known as Helomics. Helomics is currently collaborating with the School of Medicine at Pittsburg University in order to study how AI can be tapped to improve the way clinicians make decisions about ovarian cancer patients. A lot is at stake, as approximately 22,000 American women receive an ovarian cancer diagnosis each year.

NOTE TO INVESTORS: The latest news and updates relating to Predictive Oncology (NASDAQ: POAI) are available in the company’s newsroom at http://ibn.fm/POAI

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $POAI Study Discovers That Protein Imbalance May Cause Cataracts

$MGROF Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

  • Studies confirm natural active ingredient, which is in MustGrow’s biopesticide, has a positive impact on soil health
  • Soil micro-organisms play crucial role in soil fertility, plant health
  • MustGrow’s safe, effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism

MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has released study findings that confirm that the active ingredient in its mustard plant-based technology actually has a positive impact on soil health (https://ibn.fm/AeMYp). The studies have found that an application of the natural ingredient Allyl Isothiocyanate (“AITC”) returns organic plant material to the soil and contributes to the environmental and ecological security of the plant-based food supply as well as the planet generally.

“The active ingredient, AITC, in MustGrow’s mustard plant-based technology is perfect for use in modern, more sustainable pest control strategies,” said MustGrow scientific advisor Dr. Matthew J. Morra. “A biopesticide that is effective, dissipates quickly, leaves no harmful residues, and once gone, improves the soil ecosystem.” A professor emeritus of soil biochemistry at the University of Idaho, Morra is a leading world expert on products derived from oilseeds; he also has impressive expertise in developing mustard-based biopesticides.

Highlights from the study, which was separate from MustGrow, indicate that an application of AITC returns organic plant material to the soil, improves the environmental and ecological security of the planet, and creates a healthy microbial ecological environment for soil, which increases beneficial bacteria. In addition, AITC dissipates from the soil quickly, thereby eliminating any potential long-term toxicity to microorganisms.

The potential impact of MustGrow’s biopesticide on the soil cannot be overlooked. Soil micro-organisms play a crucial role in soil fertility and plant health. The use of synthetic chemicals in soil fumigation has been proven to harm beneficial micro-organisms, fungi and bacteria in the soil, actually creating a negative impact on soil fertility, plant health and nutrient transformation. So the now-verified positive impact that AITC has on soil is significant. Studies and research done on AITC have consistently concluded that the ingredient has a positive effect on the environmental and ecological security of the planet.

MustGrow’s remarkably safe and effective natural biopesticide is plant based, derived from the mustard seed’s natural defense mechanism to control diseases, pests and weeds with an organic food-grade biopesticide. The product is applied to the soil before seeds are planted. There is a growing interest in safe, effective, and plant-based biopesticides as farmers, consumers and investors alike become more aware of and committed to natural alternatives to synthetic chemical pesticides.

An agriculture biotech company, MustGrow is focused on providing natural, science-based biological solutions for high-value crops such as fruits and vegetables. The company is ideally positioned to leverage the growing momentum favoring alternatives to synthetic chemicals. As global agriculture looks to move closer to sustainable ways of boosting yields and crop protection, MustGrow continues to position itself as an essential part of the food landscape of the future with its mustard plant-based biopesticide.

For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at https://ibn.fm/MGROF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $MGROF Reports Its Plant-Based Biopesticide Has Positive Impact on Soil Health

$KAVL Announces New Distribution Partners, Significant Network Expansion to Over 46K Stores

Kaival Brands (OTCQB: KAVL), a company focused on generating stockholder value by incubating innovative products into mature and dominant brands, is the exclusive global distributor of all products manufactured by Bidi Vapor LLC. Bidi Vapor’s primary offering, the Bidi(R) Stick, is the fastest-growing closed system vaping product in the U.S. and the only vape product on the market with an ecologically friendly, mass-recycling program. Kaival Brands today announced three new distribution partners for Bidi Vapor’s vaping products. These include: Smoker Friendly International, an industry-leading tobacco-shop chain; Avail Vapor LLC, a 12-state vape-store network (tobacco behemoth Altria recently became a minority owner); and Hilmes Distributing, a large Midwest wholesaler. According to the update, the additional distribution agreements push the potential store count for Bidi Vapor products to over 46,000, up from 10,000 for all of 2020. “These new partners will become a large new revenue stream for Bidi and Kaival,” said Niraj Patel, CEO of Kaival Brands. “It is important to note our 2020 sales of just under $100 million were achieved with a distribution network of 10,000 stores and in less than 10 months of operation. Today’s new distribution partner announcements bring our network to over 46,000 store locations. The strength and breadth of these partnerships fuels our confidence in our ability to meet or exceed our 2021 projection of $400 -450 million in sales.”

To view the full press release, visit http://ibn.fm/fCG8v

About Kaival Brands Innovations Group Inc.

Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $KAVL Announces New Distribution Partners, Significant Network Expansion to Over 46K Stores

$EXN Strikes Silver at Silver City Project in Saxony

  • Company announced discovery of high-grade silver mineralization at Grauer Wolf target
  • Excellon continues to develop and test new targets along the 36-kilometer strike length
  • EXN advancing a precious metals growth pipeline in Idaho, Mexico and Germany

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FSE: E4X2), a silver and base metals producer with operations in Mexico and precious metal exploration projects in Mexico, Idaho and Germany, has announced a new discovery. The discovery of high-grade silver mineralization comes at Grauer Wolf, the fourth target drilled at EXN’s Silver City project (https://ibn.fm/1vKtG).

According to the announcement, the discovery is located on a geological site with little historical mining and adds a fourth priority area for follow-up in the 2021 drilling program at Silver City. With eight holes still outstanding, there is strong potential for additional discoveries in parallel strikes. The company is in the process of planning and preparing for more extensive drilling for its Bräunsdorf, Reichenbach, Peter Vein and now Grauer Wolf projects.

Excellon is focused on advancing a precious metals growth pipeline through exploration and development of projects that include:

  • Platosa — 11,000 hectares hosting the highest-grade silver mine in Mexico and 100% owned by EXN (https://ibn.fm/vCZjs)
  • Kilgore — 6,788 hectare high-quality gold development project in Idaho and 100% owned by EXN (https://ibn.fm/StydP)
  • Silver City — high-grade epithermal silver district in Saxony, Germany with the option to own 100% (https://ibn.fm/N8Jm9)

The 16,400-hectare Silver City project has been mined for 750 years. Records indicate high-grade silver production in excess of 1,000 g/t was mined throughout the area. Mining slowed to a standstill in the late-19th century after Germany dropped the silver standard in 1873 and the gold/silver ratio skyrocketed when silver prices plummeted. EXN is the first modern-day exploration program to focus on precious metals throughout the area, and the company is already seeing promising results.

Thanks to this new discovery, Grauer Wolf is now the fourth priority area for follow-up in the Silver City 2021 drilling program. Lesser known and located 1.5 kilometers north of the Reichenbach target, Grauer Wolf is a relatively unexploited mafiac volcanic contact. EXN continues to develop and test new targets along the Silver City Project, a 36-kilometer strike length on the Bräunsdorf license that historical records indicate has produced at least 882 tonnes of silver as well as zinc and lead (https://ibn.fm/dfDzR). Many of the vein systems under this license have only been mined at shallow depths leaving the potential for many new discoveries.

Excellon’s vision is to create wealth by realizing strategic opportunities through discipline and innovation for the benefit of its employees, communities and shareholders. The company also aims to continue capitalizing on current market conditions by acquiring undervalued projects.

For more information, visit the company’s website at www.ExcellonResources.com.

NOTE TO INVESTORS: The latest news and updates relating to EXN are available in the company’s newsroom at https://ibn.fm/EXN

About MiningNewsWire 

MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.

To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.MiningNewsWire.com

Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer

MiningNewsWire
Los Angeles, California
www.MiningNewsWire.com
310.299.1717 Office
Editor@MiningNewsWire.com

MiningNewsWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $EXN Strikes Silver at Silver City Project in Saxony

$CNSP Announces Progress Toward Upcoming Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today confirmed that the clinical program for Berubicin is on track to start enrolling patients in March 2021. CNS’ lead product candidate, Berubicin, is a novel anthracycline and the first anthracycline to cross the blood-brain barrier and is in development for the treatment of a number of serious brain and CNS oncology indications. The upcoming, potentially pivotal study will evaluate the efficacy of Berubicin in the treatment of adult glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “I am very pleased with our progress and the team’s execution towards the start of our program. We have made significant advancements and are now finalizing clinical site selection and preparing to begin patient screening, which we expect to commence next month,” said John Climaco, CEO of CNS Pharmaceuticals. “Berubicin’s promising results demonstrated in the Phase 1 clinical trial build on sixty years of clinical experience with anthracyclines. Berubicin is an entirely novel molecule that represents an opportunity to recognize the powerful benefits of this tried-and-true class of drugs for neuro-oncology in general and in the fight against GBM in particular. We are deeply committed to driving this program forward as expeditiously as possible with the prime focus on our mission to improve patient outcomes for GBM.”

To view the full press release, visit http://ibn.fm/DEZCQ

About CNS Pharmaceuticals Inc.

CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial the overall response rate of stable disease or better was 44%. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of Feb. 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of the first quarter of 2021, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the U.S., while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. Its second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies that it is 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $CNSP Announces Progress Toward Upcoming Berubicin Trial

$MOTNF Announces Excess Electricity Generated by PowerTap’s Blue Hydrogen Fueling Technology

Clean Power Capital (CSE: MOVE) (FWB: 2K6) (OTC: MOTNF), an investment company, has announced that the third-generation technology of PowerTap Hydrogen Fueling Corp., an investee company of Clean Power, has electricity-generating capability. Clean Power made the announcement as Texas has experienced severe weather resulting in widespread electricity outages. In the announcement, the company noted that while designing its onsite Blue Hydrogren fueling tech, PowerTap knew that electricity shortages were a possibility in areas where the hydrogen fueling stations would be installed. In order to produce enough electricity to keep the fueling stations open, PowerTap’s third-generation onsite hydrogen fueling units all feature an industrial hydrogen fuel cell, which can be used to turn excess hydrogen into electricity. Clean Power invested in PowerTap last year. “We have taken the patented second-generation PowerTap technology, which is in use in private and public hydrogen fueling stations in the United States, and enhanced the technology for the coming Hydrogen Highway,” said PowerTap COO Kelley Owen in the press release.

To view the full press release, visit http://ibn.fm/so3ub

About Clean Power Capital Corp.

Clean Power is an investment company that specializes in investing into private and public companies opportunistically that may be engaged in a variety of industries, with a current focus in the health and renewable energy industries. In particular, the investment mandate is focused on high-return investment opportunities, the ability to achieve a reasonable rate of capital appreciation and to seek liquidity in its investments. For more information about the company, please visit www.CleanPower.Capital.

NOTE TO INVESTORS: The latest news and updates relating to MOTNF are available in the company’s newsroom at http://ibn.fm/MOTNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, February 25th, 2021 Uncategorized Comments Off on $MOTNF Announces Excess Electricity Generated by PowerTap’s Blue Hydrogen Fueling Technology